Slide 1: Earnings Call – Q1 - FY25
Earnings Call – Q1 - FY25 January 7, 2025 1
Slide 2: Safe Harbor Statement
Safe Harbor Statement Except for historical information, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties. Words like “believe,” “expect,” and “anticipate” mean that these are our best estimates as of this writing, but there can be no as
Slide 3: First Quarter Highlights
First Quarter Highlights CURRENT PERIOD $18.9M +31% $0.01 $0.17 24% Revenue Revenue Diluted EPS Adj. Adj. EBITDA Growth Diluted EPS Margin Prior Year Comparison (1Q24) $14.5M +21% $0.10 $0.18 23% Revenue Revenue Diluted EPS Adj. Adj. EBITDA Growth Diluted EPS Margin 3
Slide 4: Trailing Twelve Months (TTM) 1Q25 Highlights
Trailing Twelve Months (TTM) 1Q25 Highlights CURRENT PERIOD $74.4M +20% $0.40 $0.94 29% Revenue Revenue Diluted EPS Adj. Adj. EBITDA Growth Diluted EPS Margin Prior Year Comparison (1Q24) $62.1M +16% $0.52 $1.06 34% Revenue Revenue Growth Diluted EPS Adj. Adj. EBITDA Diluted EPS Margin 4
Slide 5: Software Highlights
Software Highlights – Overall software revenue growth of 41% for 1Q25 and 16% for TTM General – – Good renewal rate, upsell and new logo activity Revenue contribution from ALI and MC in-line with expectations Cheminformatics Physiologically Clinical Quantitative Adaptive Learning & Medical (CHEM) Ba
Slide 6: Services Highlights
Services Highlights – Overall services revenue growth of 19% for 1Q25 and 26% for TTM General – – Total backlog $17.3M, over 90% expected to be converted to revenue within 12 months Revenue contribution from MC in-line with expectations Clinical Physiologically Physiologically Clinical Quantitative
Slide 7: Financial Results
Financial Results
Slide 8: Revenue - Q1
Revenue - Q1 (in millions) 1Q25 Mix +31% +41% +19% Total Revenue Software Revenue Services Revenue Growth Growth Growth 1Q24 Mix 8
Slide 9: Revenue - Trailing Twelve Months (TTM)
Revenue - Trailing Twelve Months (TTM) (in millions) 1Q25 Mix +20% +16% +26% Total Revenue Software Revenue Services Revenue Growth Growth Growth 1Q24 Mix 9
Slide 10: Software Solutions as % of Software Revenue
Software Solutions as % of Software Revenue 1Q25 TTM First Quarter Highlights GastroPlus® ▪ 2 new customers ▪ 4 upsells to existing customers MonolixSuite ▪ 12 new customers ▪ 9 upsells to existing customers ADMET Predictor® ▪ 4 new customers ▪ 1 upsells to existing customers QSP ▪ Added model licen
Slide 11: Software Performance Metrics - Q1
Software Performance Metrics - Q1 Commercial Customers Avg. Revenue per Customer Renewal Rates (in thousands) 11
Slide 12: Software Performance Metrics - TTM
Software Performance Metrics - TTM Commercial Customers Avg. Revenue per Customer Renewal Rates (in thousands) 12
Slide 13: Services Solutions as % of Services Revenue
Services Solutions as % of Services Revenue 1Q25 TTM 13
Slide 14: Services Performance Metrics
Services Performance Metrics Total Projects Backlog (in millions) 14
Slide 15: Income Statement Summary
Income Statement Summary (1) (in millions, except Diluted EPS and Adjusted Diluted EPS) 1Q25 % of Rev 1Q24 (2) % of Rev Revenue $18.9 100% $14.5 100% Cost of revenue 8.7 46% 4.7 32% Gross profit 10.2 54% 9.0 62% R&D 1.8 10% 1.2 8% S&M 2.9 15% 2.0 14% G&A 5.4 28% 4.9 34% Total operating exp 10.1 53%
Slide 16: Balance Sheet Summary
Balance Sheet Summary (in millions) November 30, 2024 August 31, 2024 Cash and short-term investments $18.2 $20.3 Total current assets 40.4 39.3 Total assets $196.9 $196.6 Current liabilities 9.7 12.1 Long-term liabilities 2.5 2.1 Total liabilities 12.2 14.2 Shareholders’ equity 184.7 182.4 Total li
Slide 17: Fiscal 2025 Guidance
Fiscal 2025 Guidance Guidance Total Revenue $90M - $93M Total Revenue Growth 28% - 33% Software Revenue Mix 55% - 60% Adjusted EBITDA(1) Margin 31% - 33% Adjusted Diluted EPS(2) $1.07 - $1.20 (1) Adjusted EBITDA represents net income excluding the effect of interest expense (income), provision (bene
Slide 18: Conclusion
Conclusion CONTINUED LEADERSHIP POSITION IN LIFE SCIENCES TECHNOLOGY MARKET Delivering on our Developing organization to Expanding our software and commitment to scientific Creating shareholder value drive growth services portfolio leadership • Release of GastroPlusX • Optimization of business • ALI
Slide 19: Adjusted EBITDA Non-GAAP Reconciliation
Adjusted EBITDA Non-GAAP Reconciliation (1) (in millions) FY24 FY25 FY24 Q1 Q2 Q3 Q4 Q1 Full Year Net Income $1.945 $4.029 $3.137 $0.843 $0.206 $9.954 Excluding: Interest income and expense, net (1.292) (1.348) (1.522) (0.213) (0.159) (4.375) Provision for income taxes 0.461 1.223 0.753 0.020 0.064
Slide 20: Adjusted Diluted EPS Non-GAAP Reconciliation
Adjusted Diluted EPS Non-GAAP Reconciliation (1) (in millions, except Diluted EPS and Adjusted Diluted EPS) FY24 FY25 FY24 Q1 Q2 Q3 Q4 Q1 Full Year Net Income (GAAP) $1.945 $4.029 $3.137 $0.843 $0.206 $9.954 Excluding: Amortization 0.991 0.991 1.122 2.059 2.130 5.163 Stock-based compensation 1.303 1
Slide 21: Investor Relations Contact
Investor Relations Contact: Lisa Fortuna Financial Profiles 310-622-8251 slp@finprofiles.com